Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 An unusual case of oesophageal adenocarcinoma presenting with subcutaneous metastases.

Literature DB >> 24781303

An unusual case of oesophageal adenocarcinoma presenting with subcutaneous metastases.

Duy Nguyen¹, Shamoon Siraj, Charles Ngu, Genevieve Bennett, Ganesalingam Pranavan.

Abstract

Entities: Disease

Mesh：

Year: 2014 PMID： 24781303 DOI： 10.1007/s12029-014-9614-y

Source DB: PubMed Journal: J Gastrointest Cancer

Keyword Cloud
References

× No keyword cloud information.

9 in total

1. Symptoms, investigations and management of patients with cancer of the oesophagus and gastro-oesophageal junction in Australia.

Authors: Bernard M Smithers; Paul P Fahey; Tracie Corish; David C Gotley; Gregory L Falk; Garett S Smith; George K Kiroff; Andrew D Clouston; David I Watson; David C Whiteman
Journal: Med J Aust Date: 2010-11-15 Impact factor: 7.738

2. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Authors: Yung-Jue Bang; Eric Van Cutsem; Andrea Feyereislova; Hyun C Chung; Lin Shen; Akira Sawaki; Florian Lordick; Atsushi Ohtsu; Yasushi Omuro; Taroh Satoh; Giuseppe Aprile; Evgeny Kulikov; Julie Hill; Michaela Lehle; Josef Rüschoff; Yoon-Koo Kang
Journal: Lancet Date: 2010-08-19 Impact factor: 79.321

Review 9. Cutaneous metastatic disease.

Authors: R A Schwartz
Journal: J Am Acad Dermatol Date: 1995-08 Impact factor: 11.527

9 in total

An unusual case of oesophageal adenocarcinoma presenting with subcutaneous metastases.

1. Symptoms, investigations and management of patients with cancer of the oesophagus and gastro-oesophageal junction in Australia.

2. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Review 3. Esophageal carcinoma advances in treatment results for locally advanced disease: review.

4. Asymptomatic muscle metastases from esophageal adenocarcinoma.

5. Rates of cutaneous metastases from different internal malignancies: experience from a Taiwanese medical center.

6. National Cancer Data Base report on esophageal carcinoma.

7. Cutaneous metastasis: a meta-analysis of data.

8. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma.

Review 9. Cutaneous metastatic disease.